Financhill
Sell
15

XAIR Quote, Financials, Valuation and Earnings

Last price:
$0.81
Seasonality move :
-15.34%
Day range:
$0.87 - $0.95
52-week range:
$0.67 - $6.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.79x
P/B ratio:
0.51x
Volume:
310.8K
Avg. volume:
714.1K
1-year change:
-83.49%
Market cap:
$4.1M
Revenue:
$3.7M
EPS (TTM):
-$5.42

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
XAIR
Beyond Air, Inc.
$2.1M -$0.54 99.89% -74.8% $8.67
AORT
Artivion, Inc.
$116.4M $0.18 16.97% -75% $51.43
EW
Edwards Lifesciences Corp.
$1.5B $0.62 13.01% 16.86% $96.46
NTRB
Nutriband, Inc.
$765K -$0.17 4.52% -54.85% $15.00
PETV
PetVivo Holdings, Inc.
$350K -- 178.67% -- --
ZBH
Zimmer Biomet Holdings, Inc.
$2.2B $2.40 8.14% 103.68% $102.65
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
XAIR
Beyond Air, Inc.
$0.89 $8.67 $4.1M -- $0.00 0% 0.79x
AORT
Artivion, Inc.
$38.55 $51.43 $1.8B 192.94x $0.00 0% 4.06x
EW
Edwards Lifesciences Corp.
$87.18 $96.46 $50.6B 48.26x $0.00 0% 8.42x
NTRB
Nutriband, Inc.
$4.31 $15.00 $52.4M -- $0.00 0% 21.51x
PETV
PetVivo Holdings, Inc.
$0.78 -- $27.3M -- $0.00 0% 19.25x
ZBH
Zimmer Biomet Holdings, Inc.
$99.49 $102.65 $19.5B 28.05x $0.24 0.97% 2.40x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
XAIR
Beyond Air, Inc.
74.42% 1.069 665.77% 3.81x
AORT
Artivion, Inc.
36.58% 1.968 11.85% 1.52x
EW
Edwards Lifesciences Corp.
6.39% -0.166 1.43% 2.70x
NTRB
Nutriband, Inc.
3.31% 2.020 0.32% 7.07x
PETV
PetVivo Holdings, Inc.
2.05% 1.958 0.18% 0.20x
ZBH
Zimmer Biomet Holdings, Inc.
37.91% -1.088 44.08% 0.93x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
XAIR
Beyond Air, Inc.
$300K -$6.6M -119.52% -248.25% -300.64% -$4.3M
AORT
Artivion, Inc.
$69.7M $12.5M 1.44% 2.6% 10.76% -$6.2M
EW
Edwards Lifesciences Corp.
$1.2B $377.5M 9.62% 10.27% 24.05% $353.5M
NTRB
Nutriband, Inc.
$63K -$3.9M -159.71% -164.64% -1121.15% -$1.8M
PETV
PetVivo Holdings, Inc.
$10K -$2.2M -227.61% -335.08% -765.99% -$1.4M
ZBH
Zimmer Biomet Holdings, Inc.
$1.3B $282.9M 3.53% 5.61% 12.61% $358.3M

Beyond Air, Inc. vs. Competitors

  • Which has Higher Returns XAIR or AORT?

    Artivion, Inc. has a net margin of -347.77% compared to Beyond Air, Inc.'s net margin of 2.09%. Beyond Air, Inc.'s return on equity of -248.25% beat Artivion, Inc.'s return on equity of 2.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air, Inc.
    13.67% -$0.85 $31.9M
    AORT
    Artivion, Inc.
    60.06% $0.05 $706.7M
  • What do Analysts Say About XAIR or AORT?

    Beyond Air, Inc. has a consensus price target of $8.67, signalling upside risk potential of 873.02%. On the other hand Artivion, Inc. has an analysts' consensus of $51.43 which suggests that it could grow by 33.41%. Given that Beyond Air, Inc. has higher upside potential than Artivion, Inc., analysts believe Beyond Air, Inc. is more attractive than Artivion, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air, Inc.
    2 1 0
    AORT
    Artivion, Inc.
    4 1 0
  • Is XAIR or AORT More Risky?

    Beyond Air, Inc. has a beta of 0.409, which suggesting that the stock is 59.117% less volatile than S&P 500. In comparison Artivion, Inc. has a beta of 1.596, suggesting its more volatile than the S&P 500 by 59.647%.

  • Which is a Better Dividend Stock XAIR or AORT?

    Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Artivion, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. Artivion, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or AORT?

    Beyond Air, Inc. quarterly revenues are $2.2M, which are smaller than Artivion, Inc. quarterly revenues of $116M. Beyond Air, Inc.'s net income of -$7.6M is lower than Artivion, Inc.'s net income of $2.4M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while Artivion, Inc.'s PE ratio is 192.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 0.79x versus 4.06x for Artivion, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air, Inc.
    0.79x -- $2.2M -$7.6M
    AORT
    Artivion, Inc.
    4.06x 192.94x $116M $2.4M
  • Which has Higher Returns XAIR or EW?

    Edwards Lifesciences Corp. has a net margin of -347.77% compared to Beyond Air, Inc.'s net margin of 4.09%. Beyond Air, Inc.'s return on equity of -248.25% beat Edwards Lifesciences Corp.'s return on equity of 10.27%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air, Inc.
    13.67% -$0.85 $31.9M
    EW
    Edwards Lifesciences Corp.
    78.61% $0.11 $11B
  • What do Analysts Say About XAIR or EW?

    Beyond Air, Inc. has a consensus price target of $8.67, signalling upside risk potential of 873.02%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $96.46 which suggests that it could grow by 10.65%. Given that Beyond Air, Inc. has higher upside potential than Edwards Lifesciences Corp., analysts believe Beyond Air, Inc. is more attractive than Edwards Lifesciences Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air, Inc.
    2 1 0
    EW
    Edwards Lifesciences Corp.
    16 12 0
  • Is XAIR or EW More Risky?

    Beyond Air, Inc. has a beta of 0.409, which suggesting that the stock is 59.117% less volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.927, suggesting its less volatile than the S&P 500 by 7.349%.

  • Which is a Better Dividend Stock XAIR or EW?

    Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or EW?

    Beyond Air, Inc. quarterly revenues are $2.2M, which are smaller than Edwards Lifesciences Corp. quarterly revenues of $1.6B. Beyond Air, Inc.'s net income of -$7.6M is lower than Edwards Lifesciences Corp.'s net income of $64.2M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while Edwards Lifesciences Corp.'s PE ratio is 48.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 0.79x versus 8.42x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air, Inc.
    0.79x -- $2.2M -$7.6M
    EW
    Edwards Lifesciences Corp.
    8.42x 48.26x $1.6B $64.2M
  • Which has Higher Returns XAIR or NTRB?

    Nutriband, Inc. has a net margin of -347.77% compared to Beyond Air, Inc.'s net margin of -1118.87%. Beyond Air, Inc.'s return on equity of -248.25% beat Nutriband, Inc.'s return on equity of -164.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air, Inc.
    13.67% -$0.85 $31.9M
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
  • What do Analysts Say About XAIR or NTRB?

    Beyond Air, Inc. has a consensus price target of $8.67, signalling upside risk potential of 873.02%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 248.03%. Given that Beyond Air, Inc. has higher upside potential than Nutriband, Inc., analysts believe Beyond Air, Inc. is more attractive than Nutriband, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air, Inc.
    2 1 0
    NTRB
    Nutriband, Inc.
    1 0 0
  • Is XAIR or NTRB More Risky?

    Beyond Air, Inc. has a beta of 0.409, which suggesting that the stock is 59.117% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.801, suggesting its more volatile than the S&P 500 by 80.088%.

  • Which is a Better Dividend Stock XAIR or NTRB?

    Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or NTRB?

    Beyond Air, Inc. quarterly revenues are $2.2M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. Beyond Air, Inc.'s net income of -$7.6M is lower than Nutriband, Inc.'s net income of -$3.9M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 0.79x versus 21.51x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air, Inc.
    0.79x -- $2.2M -$7.6M
    NTRB
    Nutriband, Inc.
    21.51x -- $346.1K -$3.9M
  • Which has Higher Returns XAIR or PETV?

    PetVivo Holdings, Inc. has a net margin of -347.77% compared to Beyond Air, Inc.'s net margin of -765.99%. Beyond Air, Inc.'s return on equity of -248.25% beat PetVivo Holdings, Inc.'s return on equity of -335.08%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air, Inc.
    13.67% -$0.85 $31.9M
    PETV
    PetVivo Holdings, Inc.
    3.5% -$0.07 $3.4M
  • What do Analysts Say About XAIR or PETV?

    Beyond Air, Inc. has a consensus price target of $8.67, signalling upside risk potential of 873.02%. On the other hand PetVivo Holdings, Inc. has an analysts' consensus of -- which suggests that it could grow by 541.03%. Given that Beyond Air, Inc. has higher upside potential than PetVivo Holdings, Inc., analysts believe Beyond Air, Inc. is more attractive than PetVivo Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air, Inc.
    2 1 0
    PETV
    PetVivo Holdings, Inc.
    0 0 0
  • Is XAIR or PETV More Risky?

    Beyond Air, Inc. has a beta of 0.409, which suggesting that the stock is 59.117% less volatile than S&P 500. In comparison PetVivo Holdings, Inc. has a beta of 0.356, suggesting its less volatile than the S&P 500 by 64.425%.

  • Which is a Better Dividend Stock XAIR or PETV?

    Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PetVivo Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. PetVivo Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or PETV?

    Beyond Air, Inc. quarterly revenues are $2.2M, which are larger than PetVivo Holdings, Inc. quarterly revenues of $286.1K. Beyond Air, Inc.'s net income of -$7.6M is lower than PetVivo Holdings, Inc.'s net income of -$2.2M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while PetVivo Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 0.79x versus 19.25x for PetVivo Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air, Inc.
    0.79x -- $2.2M -$7.6M
    PETV
    PetVivo Holdings, Inc.
    19.25x -- $286.1K -$2.2M
  • Which has Higher Returns XAIR or ZBH?

    Zimmer Biomet Holdings, Inc. has a net margin of -347.77% compared to Beyond Air, Inc.'s net margin of 6.15%. Beyond Air, Inc.'s return on equity of -248.25% beat Zimmer Biomet Holdings, Inc.'s return on equity of 5.61%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air, Inc.
    13.67% -$0.85 $31.9M
    ZBH
    Zimmer Biomet Holdings, Inc.
    56.23% $0.70 $20.5B
  • What do Analysts Say About XAIR or ZBH?

    Beyond Air, Inc. has a consensus price target of $8.67, signalling upside risk potential of 873.02%. On the other hand Zimmer Biomet Holdings, Inc. has an analysts' consensus of $102.65 which suggests that it could grow by 3.18%. Given that Beyond Air, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Beyond Air, Inc. is more attractive than Zimmer Biomet Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air, Inc.
    2 1 0
    ZBH
    Zimmer Biomet Holdings, Inc.
    6 17 2
  • Is XAIR or ZBH More Risky?

    Beyond Air, Inc. has a beta of 0.409, which suggesting that the stock is 59.117% less volatile than S&P 500. In comparison Zimmer Biomet Holdings, Inc. has a beta of 0.585, suggesting its less volatile than the S&P 500 by 41.541%.

  • Which is a Better Dividend Stock XAIR or ZBH?

    Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zimmer Biomet Holdings, Inc. offers a yield of 0.97% to investors and pays a quarterly dividend of $0.24 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc. pays out 27.05% of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios XAIR or ZBH?

    Beyond Air, Inc. quarterly revenues are $2.2M, which are smaller than Zimmer Biomet Holdings, Inc. quarterly revenues of $2.2B. Beyond Air, Inc.'s net income of -$7.6M is lower than Zimmer Biomet Holdings, Inc.'s net income of $137.9M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while Zimmer Biomet Holdings, Inc.'s PE ratio is 28.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 0.79x versus 2.40x for Zimmer Biomet Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air, Inc.
    0.79x -- $2.2M -$7.6M
    ZBH
    Zimmer Biomet Holdings, Inc.
    2.40x 28.05x $2.2B $137.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
50
AXTI alert for Mar 3

AXT, Inc. [AXTI] is down 12.69% over the past day.

Buy
53
AAOI alert for Mar 3

Applied Optoelectronics, Inc. [AAOI] is down 5.83% over the past day.

Sell
32
TPB alert for Mar 3

Turning Point Brands, Inc. [TPB] is up 0.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock